close
close

Indonesia’s Health Sector: Five-Year Progress Review – Academia

ndonesia will usher in a new government in the coming months, underlining the need to review progress made over the past five years, especially in the health sector. The review will assess the effectiveness and efficiency of implemented programmes and is intended to help formulate strategic plans for the next five years.

There are two approaches to assessing health programmes. One is to compare actual achievements with national targets in the National Medium-Term Development Plan (MTDP) for 2020–2024, which serves as a framework for development policies, programmes and initiatives based on the President’s vision and mission.

The second is to conduct an international comparison of national achievements, which will allow Indonesia to know its global position. This is crucial to setting more realistic programs and goals in line with international standards.

Currently, eight of the fifteen goals set out in the RPJMN have been achieved or nearly achieved.

Smoking prevalence among 10-18 year-olds fell to 7.4 per cent, exceeding the target of 8.7 per cent. Obesity prevalence among adults over 18 also fell to 15.3 per cent, exceeding the target of 21.8 per cent.

The infant mortality rate (IMR) is approaching the target of 16 per 1,000 live births and currently stands at 16.9 per 1,000. The maternal mortality rate (MMR) is projected to reach the target of 183 per 100,000 live births, after reaching 189 per 100,000 in 2022.

Every Thursday

Whether you’re looking to expand your horizons or keep up to date with the latest developments, Viewpoint is a great resource for anyone looking to engage with the issues that matter most to them.

for subscribing to our newsletter!

Check your email to stay up to date with your newsletter subscription.

See more Newsletter

Meeting the seven targets is expected to be challenging. The decline in the prevalence of stunting among young children is now 21.4 per cent, well below the target of 14 per cent. HIV prevalence remains high at 1.9 per 1,000 people, down from the target of 0.8 per 1,000. The prevalence of tuberculosis (TB) is also far from the target of 190 per 100,000 people, now at 354 per 100,000.